Location: Tokyo, Japan
CIK: 0002011385 · Show all filings
Period: Q3 2026 (← Previous)
Filing Date: Oct 30, 2026
Total Value: $210M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| PHAT | Phathom Pharmaceuticals, Inc. | 1,882,039 (+26.0%) | $13.74M (-15.2%) | 6.6% | $7.30 | $10.94 | -33.3% | COM | 71722W107 |
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | 7,799,518 (-1.3%) | $196M (-8.1%) | 93.4% | $25.13 | $7.96 | +215.8% | COM | 603170101 |